Sarah Yentz MD
Clinical Associate Professor of Internal Medicine
Internal Medicine
1500 E Medical Center Dr., C426 MIB
Ann Arbor, MI 48109
[email protected]

Available to mentor
Sarah Yentz MD
Clinical Associate Professor
  • About
  • Links
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
    • About

    Dr. Sarah Yentz received her medical degree from the University of Michigan and completed Internal Medicine residency training at Northwestern Memorial Hospital where she served as chief resident 2014-2015. She completed her fellowship in Hematology/Oncology at the University of Michigan in 2018. She has a joint appointment with the Ann Arbor VA Hospital. She is interested in medical education and serves as an associate program director for the internal medicine residency program and teaches first year medical students as part of the medical school "Doctoring" program.

    Links
    • Sarah Yentz, MD
    • Sarah Yentz, MD Rogel Cancer Center
    Qualifications
    • Fellowship Hematology/Oncology
      University of Michigan Medical School, Internal Medicine, 2018
    • Chief Resident
      Northwestern Medicine, Chicago, 2015
    • Residency
      Northwestern Medicine, Internal Medicine, 2014
    Center Memberships
    • Center Member
      Institute for Healthcare Policy and Innovation
    Research Overview

    Medical Education
    Quality Improvement
    Clinical Research in Genitourinary Oncology and Melanoma

    Recent Publications See All Publications
    • Journal Article
      Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era.
      Gradone AL, Ma VT, Vasbinder A, Fecher LA, Yentz S, Hayek SS, Lao CD. Cancer Immunol Immunother, 2024 Oct 5; 73 (12): 259 DOI:10.1007/s00262-024-03803-5
      PMID: 39369180
    • Journal Article
      Neoadjuvant Immune Checkpoint Inhibition in Metastatic Conjunctival Melanoma.
      Fan K, Waninger JJ, Yentz S, McLean S, Demirci H. Ophthalmic Plast Reconstr Surg, 2023 Sep; 39 (5): e152 - e155. DOI:10.1097/IOP.0000000000002407
      PMID: 37207285
    • Presentation
      Front-line Treatment of Metastatic RCC, OncLive State of the Science Summit
      Yentz S. 2023 Aug 1;
    • Journal Article
      A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial Cancer.
      Tsung I, Green E, Palmbos P, Sloan Z, Reichert ZR, Vaishampayan U, Smith DC, Caram MEV, Yentz S, Daignault-Newton S, Hurley L, Nguyen CB, Kraft S, Alva A. J Urol, 2023 Jan; 209 (1): 121 - 130. DOI:10.1097/JU.0000000000002969
      PMID: 36317715
    • Journal Article
      Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis.
      Vasbinder A, Chen Y, Procureur A, Gradone A, Azam TU, Perry D, Shadid H, Anderson E, Catalan T, Blakely P, Nelapudi N, Fardous M, Bretagne MC, Adie SK, Pogue KT, Leja M, Yentz S, Schneider B, Fecher LA, Lao CD, Salem J-E, Hayek SS. JACC CardioOncol, 2022 Dec; 4 (5): 689 - 700. DOI:10.1016/j.jaccao.2022.11.004
      PMID: 36636441
    • Journal Article
      Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma.
      Waninger JJ, Fecher LA, Lao C, Yentz S, Green MD, Demirci H. Cancers (Basel), 2022 Nov 24; 14 (23): DOI:10.3390/cancers14235789
      PMID: 36497270
    • Proceeding / Abstract / Poster
      Abstract 12324: Biomarker Trends in Patients With Immune-Checkpoint Inhibitor Myocarditis
      Vasbinder A, Chen Y, Gradone A, Azam T, Perry D, Shadid H, Anderson E, Catalan T, Blakely P, Adie S, Pogue K, Leja M, Yentz S, Schneider B, Fecher L, Lao CD, Hayek S. Circulation, 2022 Nov 8; 146 (Suppl_1): a12324 - a12324. DOI:10.1161/circ.146.suppl_1.12324
    • Proceeding / Abstract / Poster
      Abstract 13185: Incidence and Risk Factors of Acute Cardiovascular Complications After Hematopoietic Stem Cell Transplantation
      Vasbinder A, Anderson E, Catalan T, Chu C, Kotzin M, Azam T, Perry D, Shadid H, Rochlen M, Yentz S, Schneider B, Leja M, Lao C, Fecher L, Nathan S, Okwuosa T, Hayek S. Circulation, 2022 Nov 8; 146 (Suppl_1): a13185 - a13185. DOI:10.1161/circ.146.suppl_1.13185